(TZD) Pioglitazone, Rivoglitazone†, Rosiglitazone, Troglitazone‡Meglitinides Nateglinide, Repaglinide, MitiglinideDipeptidyl peptidase-4 (DPP-4) amaryl and weight gain Alogliptin,† Saxagliptin,† Sitagliptin, VildagliptinGlucagon-like peptide-1 analog ExenatideAmylin analog PramlintideInsulin analogs fast acting (Insulin lispro, Insulin.

improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.GlimepirideSystematic (IUPAC) name3-ethyl-N,N-bis (3-ethyl-4-methyl-2-oxo-5H-pyrrol-2-yl)- 4-methyl-2-oxo-5H-pyrrole-1- carboxamideIdentifiersCAS number 93479-97-1ATC code A10BB12PubChem 3476DrugBank APRD00381Chemical dataFormula C24H34N4O5SMol. mass 490.617 g/molPharmacokinetic dataBioavailability ?Protein binding >99.5%Metabolism ?Half life ?Excretion ?Therapeutic considerationsPregnancy cat. ?Legal amaryl and weight gain ?Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as amaryl and weight gain by Sanofi-Aventis. Glimepiride amaryl and weight gain the first third-generation amaryl and weight gain and is very potent.Contents amaryl and weight gain Indications2 Adverse effects3 Contraindications4 Interactions5 Pharmacology6 Mechanism of action[edit] IndicationsType 2 diabetes (NIDDM).[edit] Adverse effectsMain article: SulfonylureaGI disturbance, rarely thrombopenia , leucopenia, haemolytic anaemia.

Rivoglitazone†, Rosiglitazone, Troglitazone‡Meglitinides Nateglinide, Repaglinide, MitiglinideDipeptidyl peptidase-4 (DPP-4).